Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

Conditions: Oncology Patients Receiving Chemotherapy; Cachexia-Anorexia Syndrome; Oncology

Interventions: Drug: OLANZapine 2.5 MG

Sponsors: Blokhin’s Russian Cancer Research Center

Recruiting